Black RS - Search Results

1

Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.

Bombois S, Maurage CA, Gompel M, Deramecourt V, Mackowiak-Cordoliani MA, Black RS, Lavielle R, Delacourte A, Pasquier F. Bombois S, et al. Among authors: black rs. Arch Neurol. 2007 Apr;64(4):583-7. doi: 10.1001/archneur.64.4.583. Arch Neurol. 2007. PMID: 17420322

2

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M; AN1792(QS-21)-201 Study. Fox NC, et al. Among authors: black rs. Neurology. 2005 May 10;64(9):1563-72. doi: 10.1212/01.WNL.0000159743.08996.99. Neurology. 2005. PMID: 15883317 Clinical Trial.

3

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Rovira MB, Forette F, Orgogozo JM; AN1792(QS-21)-201 Study Team. Gilman S, et al. Among authors: black rs. Neurology. 2005 May 10;64(9):1553-62. doi: 10.1212/01.WNL.0000159740.16984.3C. Neurology. 2005. PMID: 15883316 Clinical Trial.

4

A neuropsychological test battery for use in Alzheimer disease clinical trials.

Harrison J, Minassian SL, Jenkins L, Black RS, Koller M, Grundman M. Harrison J, et al. Among authors: black rs. Arch Neurol. 2007 Sep;64(9):1323-9. doi: 10.1001/archneur.64.9.1323. Arch Neurol. 2007. PMID: 17846273 Clinical Trial.

5

Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.

Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR Jr, Weiner M, DeCarli C; Alzheimer's Disease Neuroimaging Initiative. Carmichael O, et al. Arch Neurol. 2010 Nov;67(11):1370-8. doi: 10.1001/archneurol.2010.284. Arch Neurol. 2010. PMID: 21060014 Free PMC article. Clinical Trial.

6

Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC. Ridha BH, et al. Among authors: black rs. J Neurol. 2008 Apr;255(4):567-74. doi: 10.1007/s00415-008-0750-9. Epub 2008 Feb 18. J Neurol. 2008. PMID: 18274807 Clinical Trial.

7

Risk factors associated with beta-amyloid(1-42) immunotherapy in preimmunization gene expression patterns of blood cells.

O'Toole M, Janszen DB, Slonim DK, Reddy PS, Ellis DK, Legault HM, Hill AA, Whitley MZ, Mounts WM, Zuberek K, Immermann FW, Black RS, Dorner AJ. O'Toole M, et al. Among authors: black rs. Arch Neurol. 2005 Oct;62(10):1531-6. doi: 10.1001/archneur.62.10.1531. Arch Neurol. 2005. PMID: 16216935 Clinical Trial.

8

A trial of thiamine in Alzheimer's disease.

Nolan KA, Black RS, Sheu KF, Langberg J, Blass JP. Nolan KA, et al. Among authors: black rs. Arch Neurol. 1991 Jan;48(1):81-3. doi: 10.1001/archneur.1991.00530130093025. Arch Neurol. 1991. PMID: 1986730 Clinical Trial.

9

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.

Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E; AAB-001 201/202 Investigators. Blennow K, et al. Arch Neurol. 2012 Aug;69(8):1002-10. doi: 10.1001/archneurol.2012.90. Arch Neurol. 2012. PMID: 22473769 Clinical Trial.

10

Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.

Lee M, Bard F, Johnson-Wood K, Lee C, Hu K, Griffith SG, Black RS, Schenk D, Seubert P. Lee M, et al. Among authors: black rs. Ann Neurol. 2005 Sep;58(3):430-5. doi: 10.1002/ana.20592. Ann Neurol. 2005. PMID: 16130106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters